Calf Deep Vein Thrombosis Treatment Trial

Summary

The primary objective is to evaluate whether apixaban is more effective in treating patients with isolated calf vein thrombosis (DVT) than serial imaging of the DVT for preventing thrombus spread, pulmonary embolism (PE) and/or recurring DVTs.

Timeline

Start

2019-02-19

Primary completion

2019-06-03

Completion

2019-06-03

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of participant enrollment”

Drugs

Indications